4 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potency.

Aventis Pharma
Synthesis and biological activity of pyridopyridazin-6-one p38a MAP kinase inhibitors. Part 2.

Merck Research Laboratories
Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinones.

Merck Research Laboratories